Daniela Farkas

486 total citations
13 papers, 359 citations indexed

About

Daniela Farkas is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Daniela Farkas has authored 13 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Daniela Farkas's work include Pulmonary Hypertension Research and Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Daniela Farkas is often cited by papers focused on Pulmonary Hypertension Research and Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Daniela Farkas collaborates with scholars based in United States, United Kingdom and Slovakia. Daniela Farkas's co-authors include Donatas Kraskauskas, Jacob A. Wegelin, Donald F. Brophy, Erika J. Martin, Alpha A. Fowler, Bernard Fisher, Norbert F. Voelkel, Ramesh Natarajan, Kevin R. Ward and László Farkas and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and PLoS Pathogens.

In The Last Decade

Daniela Farkas

11 papers receiving 353 citations

Peers

Daniela Farkas
V. D’Souza United Kingdom
Scott C. Fligor United States
An Zhang China
Cheryl A. Woolsey United States
V. D’Souza United Kingdom
Daniela Farkas
Citations per year, relative to Daniela Farkas Daniela Farkas (= 1×) peers V. D’Souza

Countries citing papers authored by Daniela Farkas

Since Specialization
Citations

This map shows the geographic impact of Daniela Farkas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Farkas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Farkas more than expected).

Fields of papers citing papers by Daniela Farkas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Farkas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Farkas. The network helps show where Daniela Farkas may publish in the future.

Co-authorship network of co-authors of Daniela Farkas

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Farkas. A scholar is included among the top collaborators of Daniela Farkas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Farkas. Daniela Farkas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Klamer, Brett, Daniela Farkas, J.D. Londino, et al.. (2025). Plasma proteomic profiles correlate with organ dysfunction in COVID‐19 ARDS. Physiological Reports. 13(7). e70300–e70300.
2.
Ali, Mehboob, Mingjun Liu, Neil J. Kelly, et al.. (2023). A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3. iScience. 26(2). 105935–105935. 11 indexed citations
3.
Gloag, Erin S., Jianying Li, Daniela Farkas, et al.. (2022). Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2. PLoS Pathogens. 18(3). e1010093–e1010093. 29 indexed citations
4.
Link, Patrick A., Daniela Farkas, Brennan Harmon, et al.. (2022). Dichotomous role of integrin‐β5 in lung endothelial cells. Pulmonary Circulation. 12(4). e12156–e12156. 10 indexed citations
5.
Farkas, Daniela, A. A. Roger Thompson, Hyun Ji, et al.. (2018). Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 199(2). 199–210. 50 indexed citations
6.
Farkas, Daniela, et al.. (2016). Longitudinal enlargement of the lesion after spinal cord injury in the rat: a consequence of malignant edema?. Spinal Cord. 55(3). 255–263. 15 indexed citations
7.
Bagnato, Gianluca, László Farkas, Jose Gomez‐Arroyo, et al.. (2012). Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats. European Respiratory Journal. 41(1). 104–114. 46 indexed citations
8.
Farkas, László, Donatas Kraskauskas, Daniela Farkas, et al.. (2012). Inflammation Is Required For The Initiation Of Angioproliferative PAH. A1232–A1232.
9.
Fisher, Bernard, Donatas Kraskauskas, Erika J. Martin, et al.. (2012). Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid. American Journal of Physiology-Lung Cellular and Molecular Physiology. 303(1). L20–L32. 179 indexed citations
10.
Gomez‐Arroyo, Jose, Karol Szczepanek, Aamer Syed, et al.. (2012). Metabolic Remodeling In Right Ventricular Failure Is Associated With Abnormal Mitochondrial Biogenesis. A3455–A3455. 1 indexed citations
11.
Farkas, László, Daniela Farkas, Donatas Kraskauskas, et al.. (2011). Potential Contribution Of Precursor Cells To Angioproliferation In The SU5416/chronic Hypoxia Model Of Severe PAH. A3417–A3417. 1 indexed citations
12.
Xu, Hui, Limin Liu, László Farkas, et al.. (2010). Renal tubular angiogenic dysregulation in anti-Thy1.1 glomerulonephritis. American Journal of Physiology-Renal Physiology. 300(2). F488–F498. 8 indexed citations
13.
J, Jos, et al.. (1996). Croissance des enfants atteints de diabète insulinodépendant. Étude de 104 observations. Archives de Pédiatrie. 3(3). 218–226. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026